ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1) polymorphism and clopidogrel concentration in acute coronary syndrome: molecular change can explain the observed therapeutic concentration

Joob, Beuy; Wiwanitkit, Viroj

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes

In titles and abstracts

In keywords

In all

pdf

ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1) polymorphism and clopidogrel concentration in acute coronary syndrome: molecular change can explain the observed therapeutic concentration [Anatol J Cardiol]

Anatol J Cardiol. 2016; 16(4): 303-304 | DOI: 10.14744/AnatolJCardiol.2016.7027

ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1) polymorphism and clopidogrel concentration in acute coronary syndrome: molecular change can explain the observed therapeutic concentration

Beuy Joob¹, Viroj Wiwanitkit²
¹Sanitation 1 Medical Academic Center, Bangkok-Thailand
²Visiting Professor, Hainan Medical University, Hainan-China

Beuy Joob, Viroj Wiwanitkit. ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1) polymorphism and clopidogrel concentration in acute coronary syndrome: molecular change can explain the observed therapeutic concentration. Anatol J Cardiol. 2016; 16(4): 303-304

Corresponding Author: Beuy Joob, Thailand
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar